Article
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease.
Cell death & disease - 24 Jan 2018
Sartini Alessandro, Gitto Stefano, Bianchini Marcello, Verga Maria Chiara, Di Girolamo Maria, Bertani Angela, Del Buono Mariagrazia, Schepis Filippo, Lei Barbara, De Maria Nicola, Villa Erica
Abstract excerpt
Non-alcoholic fatty liver disease (NAFLD) can be detected in up to 33.6% of inflammatory bowel disease (IBD) patients, often in absence of metabolic risk factors. Nevertheless, most of previous studies on such issue were conducted within the IBD population only. The primary aim of this study was to compare clinical and metabolic features of NAFLD in patients with and without IBD (w/o IBD) and to identify specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
